MIUKin™

MIUKin™

(2023’ Clinical Trial scheduled)

MIUKin™ is a skin organoid-type cellular therapeutic agent based on keratinocytes and fibroblasts
derived from homozygous induced pluripotent stem cells.

CiSTEM has secured the technology for producing skin organoids consisting of keratinocytes and fibroblasts derived from induced pluripotent stem cells.